Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02754479 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation of the Treatment of Spider Veins on the Ankles
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02754479: Completed NA study, sponsored by Cutera.
NCT02754479 is a NA study that has completed, run by Cutera. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02754479, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the Excel V system for the treatment of lower extremity spider veins on the ankles.
Primary Outcome
Improvement in treated ankle spider veins at 4 weeks post final laser treatment (compared to baseline) as assessed by a blinded evaluators Physician Global Assessment Scale score (Min=0; 4= Max). Higher Score Indicates Better Outcome.
Interventions
- DEVICE Nd:YAG laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-06-10 |
| Est. Completion | 2017-03-15 |
| Phase | NA |
What the finished NCT02754479 record still lists
NCT02754479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Nd:YAG laser is the first listed.
NCT02754479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02754479 about?
NCT02754479 is a clinical study titled "A Clinical Evaluation of the Treatment of Spider Veins on the Ankles". To evaluate the safety and effectiveness of the Excel V system for the treatment of lower extremity spider veins on the ankles.
What is the current status of trial NCT02754479?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-06-10. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT02754479?
The interventions under investigation include: Nd:YAG laser (DEVICE).
Who is sponsoring clinical trial NCT02754479?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02754479's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI